An expert jury selected the 10 Venture Leaders Medtech 2022: In June, the newest members of the Swiss National Startup team will travel to Boston and Cambridge to explore the US medtech startup ecosystem and connect with investors, industry leaders, and experts. The Venture Leaders Medtech program is organized by Venturelab and supported by EPF Lausanne, ETH Zurich, Hansjörg Wyss, Helbling Technik, Kellerhals Carrard, Paul Scherrer Institut, Swissnex Boston, Canton of Vaud, Canton of Zurich, and Venture Leader alumnus Dominik Lysek.
For the second consecutive year, the Venture Leaders Medtech will represent Swiss innovation in the United States. During the week-long roadshow, the 10 Venture Leaders will pitch to key US investors and meet with leaders and experts of the medtech industry. “With its focus on quality and precision, the Swiss medtech industry provides highly specialized expertise for a global market,” said Jordi Montserrat, managing partner at Venturelab. “The innovative power of the Venture Leaders Medtech 2022 is remarkable: The solutions have the potential to transform the industry, and I am excited to introduce the entrepreneurs to Boston’s investor scene.”
aiEndoscopic AG: We combine AI with robotics to develop smart endoscopes
The current scarcity and forecasted shortage of skilled healthcare workers lead to more and more problems in experience-based tasks, such as endoscopy. aiE combines artificial intelligence with rob... Read more
Arbrea Labs AG: Growing the Medical Aesthetic Care with AI & Digital Humans
Arbrea is spearheading the aesthetic metaverse revolution with the first mobile Medical Aesthetic Marketspace powered by AI and Digital Humans. Our cutting-edge AI, AR, and 3D technologies are transfo... Read more
ArcoScreen SA: Improving drug discovery through patient cell screening.
ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary technology ... Read more
Bearmind SA: Wearable technology to prevent brain injuries in sports
Bearmind is an EPFL spin-off developing and commercializing in-built helmet sensors and software for brain injury prevention and performance monitoring in Sports. We are developing sensors and alg... Read more
EarlySight SA: Imaging early signs of retinal diseases years in advance
EarlySight is developing a medical device to help doctors detect and monitor eye diseases at early stage thanks to unprecedented imaging of the eye. Many eye diseases (e.g. AMD, glaucoma) are starti... Read more
MOMM Diagnostics AG: Rapid diagnostic tests for pregnancy complications
MOMM Diagnostics develops rapid, cost-effective diagnostic tests for pregnancy complications. préXclude® is our first test in development to diagnose and prognose preeclampsia a leading cause of death... Read more
Oncobit AG: Enabling personalised cancer care
Oncobit is a spinoff from the University Hospital of Zurich and has developed a scalable and data-driven cancer monitoring platform based on the quantitative and sensitive detection of cancer markers ... Read more
Rea Diagnostics SA: We develop technology to monitor high risk pregnancies
Rea developed the first at-home diagnostic test that tracks biochemical markers of preterm birth (PTB). Our solution allows doctors to continuously follow up pregnant women at risk of PTB to anticipat... Read more
TWIICE SA: Powered exoskeletons for walking assistance
Every year, 250000 people suffer a spinal cord injury leading to permanent paraplegia. TWIICE enables these individuals to live life to the fullest through wearable robotics. We help to overcome human... Read more